Biolinq

Biolinq is a healthcare technology company based in La Jolla, California, that specializes in precision multi-analyte wearable biosensors aimed at improving metabolic health, particularly for diabetes care. Founded in 2012 as Electrozyme LLC, Biolinq has developed a wearable patch that utilizes electrochemical sensors to monitor glucose levels just beneath the skin's surface, enabling continuous glucose monitoring without traditional blood sampling. The company's platform integrates glucose data with activity levels, providing users with real-time insights into their metabolic health. Biolinq focuses on scalable, low-cost manufacturing to facilitate widespread adoption across various sectors, including healthcare, wellness, sports, military, and environmental monitoring. With over $58 million raised for clinical trials and FDA submissions, Biolinq is transitioning towards commercial readiness, aiming to bring its innovative glucose monitoring device to market for individuals living with diabetes, especially those with Type 2 diabetes.

• Employees 190
• Founded 2012
• Annual Revenue $25000000
• Total Funding $278904335